Home › Funds › Vestal Point Capital, LP › IMCR
Vestal Point Capital, LP position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
Vestal Point Capital, LP reported holding 850,000 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$25.7M, representing 0.67% of its reported portfolio and ranking #26 among its reported holdings. Vestal Point Capital, LP has disclosed IMCR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's IMCR position evolved
Vestal Point Capital, LP first disclosed a stake in IMCR in Q4 2025 at 585,000 shares (US$20.3M). The position peaked in Q1 2026 at 2,766,868 shares, worth US$83.4M. Across 4 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 850,000 shares valued at US$25.7M — a reduction of -950,000 shares quarter over quarter.. Notable position changes include a 373% increase in Q1 2026 (shares rose 5% over the following quarter), a 35% trim in Q2 2026 (shares fell 5% over the following quarter), a 53% trim in Q3 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 585.00K | $20.31M | New |
| Q1 2026 | 2.77M | $83.42M | Add |
| Q2 2026 | 1.80M | $57.15M | Reduce |
| Q3 2026 | 850.00K | $25.75M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 27 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), TANG CAPITAL MANAGEMENT LLC (US$87.4M), Bellevue Group AG (US$68.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $147.51M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 2.88M sh · $87.36M · Q3 2026
- Bellevue Group AG 2.26M sh · $68.59M · Q3 2026
- Caligan Partners LP 1.67M sh · $50.65M · Q3 2026
- Kynam Capital Management, LP 1.38M sh · $41.65M · Q3 2026
- BVF INC/IL 1.23M sh · $37.28M · Q3 2026
- MPM BioImpact LLC 1.20M sh · $36.45M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.14M sh · $34.41M · Q3 2026
- Trails Edge Capital Partners, LP 1.06M sh · $32.21M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 928.00K sh · $28.11M · Q3 2026
- BRAIDWELL LP 906.12K sh · $27.45M · Q3 2026
- Frazier Life Sciences Management, L.P. 829.75K sh · $25.13M · Q3 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held IMCR?
Vestal Point Capital, LP has disclosed IMCR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Vestal Point Capital, LP's current position in IMCR?
As of Q3 2026, Vestal Point Capital, LP holds 850.00K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $25.75M, representing 0.67% of its reported portfolio and ranking #26.
Has Vestal Point Capital, LP been buying or selling IMCR?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP reduced its position in IMCR. The position peaked in Q1 2026 at 2.77M shares.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, Bellevue Group AG, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.